Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$222.79 USD
-0.30 (-0.13%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $222.91 +0.12 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$222.79 USD
-0.30 (-0.13%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $222.91 +0.12 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Zacks News
Is a Beat in Store for Chubb Limited (CB) in Q4 Earnings?
by Zacks Equity Research
Chubb Limited's (CB) performance is likely to have benefited from rate increases, favorable prior period reserve development and strong renewal retention.
Arthur J. Gallagher (AJG) Q4 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results reflect higher adjusted revenues and margin expansion across the Brokerage and Risk Management segments.
Marsh & McLennan (MMC) Q4 Earnings Beat on Solid US Business
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results benefit from expanding operations across Latin America and EMEA, partly offset by higher operating expenses.
Compared to Estimates, Marsh & McLennan (MMC) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Marsh & McLennan (MMC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marsh & McLennan (MMC) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 0.62%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Marsh & McLennan (MMC) Ahead of Earnings?
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Exploring Analyst Estimates for Marsh & McLennan (MMC) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Marsh & McLennan (MMC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
What's in Store for Arthur J. Gallagher (AJG) in Q4 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results are likely to reflect strong retention, new business generation, increasing renewal premiums and higher interest income, offset by higher expenses.
Is a Beat in Store for Marsh & McLennan (MMC) in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect robust international operations in the Risk and Insurance Services unit.
Marsh & McLennan (MMC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.
Marsh & McLennan (MMC) Up 14% in a Year: Upside Potential Left?
by Zacks Equity Research
Growth in the Latin America and Asia regions is expected to buoy Marsh & McLennan's (MMC) results.
Arthur J. Gallagher (AJG) Adds Koberich to its Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Koberich is set to help it consolidate its presence in Europe.
Travelers (TRV) Boosts Cyber Capabilities With Corvus Buyout
by Zacks Equity Research
Travelers (TRV) buyout of Corvus Insurance marks its step toward enhancing its cyber capabilities, a part of its strategic growth roadmap.
Brown & Brown (BRO) Expands in Florida With Caton-Hosey Buyout
by Zacks Equity Research
Brown & Brown (BRO) signs an agreement to acquire Caton-Hosey, boosting its presence in Florida.
Marsh & McLennan's (MMC) Unit Divests Atlas to Stoch Analytics
by Zacks Equity Research
Marsh & McLennan's (MMC) Oliver Wyman sells its Atlas Software business to Stoch Analytics, aiming to serve its clients better with an independent software company.
Marsh & McLennan (MMC) Unit Boosts Aviation Business With SeaTec
by Zacks Equity Research
Marsh & McLennan's (MMC) Oliver Wyman is expected to boost its presence in Aviation consulting with the acquisition of SeaTec.
Brown & Brown (BRO) Unit Expands in Automotive Aftermarket
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary, Brown & Brown Dealer Services' buyout of ABS is set to boost its presence in the warranty solutions marketplace.
Arthur J. Gallagher (AJG) Adds Evans Agency to Its Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) addition of Evans Agency to its portfolio will not only consolidate the acquirer's presence in Western New York but also enhance AJG's capabilities.
Marsh & McLennan (MMC) Unit Buys Vanguard's US OCIO Business
by Zacks Equity Research
The acquisition is expected to enhance Marsh & McLennan's (MMC) business, Mercer's strengths in OCIO and the management of alternative asset classes.
Arthur J Gallagher (AJG) Stock Up 32% YTD: More Upside Left?
by Zacks Equity Research
Arthur J Gallagher (AJG) is poised to grow from the solid performance of the Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.
AON's PEP Achieves $2Bn Milestone in U.S. Assets & Commitments
by Zacks Equity Research
AON's PEP currently serves more than 70 employers from different industries. It provides benefits in the form of increased retirement savings for employees.
Here's Why You Must Buy Brown & Brown (BRO) Stock Right Now
by Zacks Equity Research
Brown & Brown (BRO) continues to gain from robust new businesses, premium rate increases across the majority of business lines, expansion initiatives, strategic acquisitions and a strong financial position.
Marsh & McLennan (MMC) Unveils AI Tool for Operational Efficiency
by Zacks Equity Research
Marsh & McLennan (MMC) unit, Oliver Wyman, launches LenAI to benefit its colleagues with higher productivity. It is also a mean to upgrade MMC's digital capabilities.